Incyte advances multiple early-phase cancer trials with potential therapeutic breakthroughs, highlighting their strategic focus on oncology and rare diseases.
Italian authorities seize €1.3B in shares from Lagfin, the controlling shareholder of Campari, amid an ongoing tax-fraud probe.
Injury-plagued Chargers seek reinforcements before NFL trade deadline to protect star QB Herbert and maintain competitiveness.
Incyte advances multiple early-phase cancer trials with potential therapeutic breakthroughs, highlighting their strategic focus on oncology and rare diseases.
Italian authorities seize €1.3B in shares from Lagfin, the controlling shareholder of Campari, amid an ongoing tax-fraud probe.
Injury-plagued Chargers seek reinforcements before NFL trade deadline to protect star QB Herbert and maintain competitiveness.